Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Ankon Medical Technologies

Request full access

Wuhan magnetically controlled capsule gastroscopy (NaviCam)

Wuhan, ChinaFounded 2009Health Tech & Medtech

About Ankon Medical Technologies

Ankon Medical Technologies, established in 2008, operates within the gastrointestinal health sector, focusing on the development and commercialization of medical devices for digestive disease screening and diagnosis. The company was co-founded by Ji Xiao, who brings a background in Silicon Valley's optical and semiconductor industries, alongside CTO Zuo Qiang and Chief Scientist Duan Xiaodong. Ankon has achieved significant milestones, including securing China's first CFDA approval for a capsule gastroscope in 2013 and raising over $100 million in a 2017 funding round. The firm's core business revolves around its NaviCam capsule endoscopy system. This product is a magnetically controlled robotic capsule that, once swallowed, allows physicians to non-invasively and comfortably examine the stomach and upper gastrointestinal tract. The system provides an alternative to traditional, more invasive gastroscopy procedures, targeting patients and medical institutions seeking less discomfort and greater precision in early-stage cancer detection and other digestive health diagnostics. Ankon generates revenue through the sale of these capsule systems and associated equipment to hospitals and clinics. The company serves the Chinese domestic market and has expanded its presence internationally, obtaining CE marking in Europe and clearance in other regions. Its business model is based on providing a complete hardware and software solution for gastrointestinal examination, positioning itself as a key player in the preventative health and medical device market.

Source: Dealroom company data

At a glance

Outcome tier
Unicorn$1–10B valuation tierColt$25–100M revenue

Ankon Medical Technologies in the Wuhan ecosystem

Live from Dealroom

The Ankon Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • SB China Capital
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown
Web traffic by country
6.2K monthly visits
across markets
🇨🇳 China100%
Top 1 markets shown

Patents

Estimated portfolio value
$56M

429 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Ankon Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ankon Medical Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.